| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.03▼ | 10.11▼ | 10.12▼ | 9.79▲ | 10.95▼ |
| MA10 | 10.03▼ | 10.15▼ | 9.88▲ | 10.39▼ | 11.54▼ |
| MA20 | 10.09▼ | 9.86▲ | 9.83▲ | 11.24▼ | 11.82▼ |
| MA50 | 10.15▼ | 9.86▲ | 10.08▼ | 11.67▼ | 12.49▼ |
| MA100 | 9.94▲ | 10.20▼ | 10.85▼ | 12.11▼ | 11.86▼ |
| MA200 | 9.82▲ | 10.95▼ | 11.33▼ | 12.89▼ | 20.69▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.018▲ | 0.077▲ | -0.176▼ | -0.234▼ |
| RSI | 45.187▼ | 53.041▲ | 51.986▲ | 40.745▼ | 41.381▼ |
| STOCH | 47.851 | 52.607 | 82.578▲ | 10.692▼ | 22.861 |
| WILL %R | -46.667 | -29.918 | -27.547 | -73.121 | -80.903▼ |
| CCI | -78.990 | -25.038 | 49.297 | -74.572 | -213.366▼ |
|
Tuesday, November 17, 2026 04:19 AM
Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.
|
|
Wednesday, November 11, 2026 04:00 PM
Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced ...
|
|
Saturday, November 07, 2026 06:58 AM
Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/11/26 | 9.34 | 10.395 | 9.30 | 10.00 | 15,165,633 |
| 19/11/26 | 9.83 | 10.04 | 9.07 | 9.52 | 9,899,245 |
| 18/11/26 | 9.87 | 10.49 | 9.66 | 9.77 | 7,226,020 |
| 17/11/26 | 9.96 | 10.24 | 9.685 | 9.78 | 7,595,768 |
| 16/11/26 | 9.98 | 10.46 | 9.70 | 9.86 | 6,591,341 |
| 13/11/26 | 10.45 | 10.505 | 9.665 | 9.70 | 11,378,745 |
| 12/11/26 | 11.00 | 11.0551 | 10.46 | 10.55 | 4,004,652 |
| 11/11/26 | 11.30 | 11.64 | 11.125 | 11.41 | 3,035,481 |
| 10/11/26 | 11.87 | 11.92 | 10.955 | 11.17 | 4,180,525 |
| 09/11/26 | 11.36 | 12.145 | 11.15 | 12.11 | 4,167,569 |
|
|
||||
|
|
||||
|
|